Previous comprehensive genome-wide methylation analyses found changes in e.g. PGC1α, a key transcriptional regulator of mitochondrial fatty acid oxidation, has been associated with insulin resistance in NAFLD patients [8, 26]. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.